Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials

A prospective path for allogeneic cellular immunotherapies.

Oncolytic virus startup Calidi secures $25M toward Series B round

Calidi Biotherapeutics, a San Diego biotech working on developing allogeneic cell delivery of oncolytic viruses, said Friday that investors have committed $25 million to a

June 24, 2023

Radon exposure linked to increased risk of blood cell mutation in female stroke patients

Radon, a naturally occurring radioactive gas produced when metals like uranium or radium break down in rocks and soil, is a known cause of lung

January 4, 2024

Researchers identify crucial risk factors for cognitive decline after stroke

Study identifies key risk factors for post-stroke cognitive impairment and dementia, emphasizing the importance of early detection and management of these conditions.

December 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.